I agree that this site is using cookies. You can find further informations here.
X
Caenepeel, Sean
32  results:
Search for persons X
?
1

Targeting MCL-1 in hematologic malignancies: Rationale and ..:

Wei, Andrew H. ; Roberts, Andrew W. ; Spencer, Andrew...
Blood Reviews.  44 (2020)  - p. 100672 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhib..:

Rescourio, Gwenaella ; Gonzalez, Ana Z. ; Jabri, Salman...
Journal of Medicinal Chemistry.  62 (2019)  22 - p. 10258-10271 , 2019
Link: https://doi.org/10.1021/..
 
?
3

MAPK pathway inhibition induces MET and GAB1 levels, primin..:

Caenepeel, Sean ; Cooke, Keegan ; Wadsworth, Sarah...
Oncotarget.  8 (2017)  11 - p. 17795-17809 , 2017
Link: https://doi.org/10.18632..
 
?
4

Targeted Therapy and Checkpoint Immunotherapy Combinations ..:

Hughes, Paul E. ; Caenepeel, Sean ; Wu, Lawren C.
Trends in Immunology.  37 (2016)  7 - p. 462-476 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Identifying the determinants of response to MDM2 inhibition:

Saiki, Anne Y. ; Caenepeel, Sean ; Cosgrove, Elissa...
Oncotarget.  6 (2015)  10 - p. 7701-7712 , 2015
Link: https://doi.org/10.18632..
 
?
6

The imidazo[1,2-a]pyridine ring system as a scaffold for po..:

Stec, Markian M. ; Andrews, Kristin L. ; Bo, Yunxin...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  19 - p. 4136-4142 , 2015
Link: https://doi.org/10.1016/..
 
?
7

MDM2 antagonists synergize broadly and robustly with compou..:

Saiki, Anne Y. ; Caenepeel, Sean ; Yu, Dongyin...
Oncotarget.  5 (2014)  8 - p. 2030-2043 , 2014
Link: https://doi.org/10.18632..
 
?
8

Selective Class I Phosphoinositide 3-Kinase Inhibitors: Opt..:

Norman, Mark H. ; Andrews, Kristin L. ; Bo, Yunxin Y....
Journal of Medicinal Chemistry.  55 (2012)  17 - p. 7796-7816 , 2012
Link: https://doi.org/10.1021/..
 
?
9

Synthesis and structure–activity relationships of dual PI3K..:

Wurz, Ryan P. ; Liu, Longbin ; Yang, Kevin...
Bioorganic & Medicinal Chemistry Letters.  22 (2012)  17 - p. 5714-5720 , 2012
Link: https://doi.org/10.1016/..
 
?
10

Structure-Based Design of a Novel Series of Potent, Selecti..:

Smith, Adrian L. ; D'Angelo, Noel D. ; Bo, Yunxin Y....
Journal of Medicinal Chemistry.  55 (2012)  11 - p. 5188-5219 , 2012
Link: https://doi.org/10.1021/..
 
?
11

Correction to Selective Class I Phosphoinositide 3-Kinase I..:

Norman, Mark H. ; Andrews, Kristin L. ; Bo, Yunxin Y....
Journal of Medicinal Chemistry.  55 (2012)  20 - p. 8975-8975 , 2012
Link: https://doi.org/10.1021/..
 
?
12

Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapam..:

Nishimura, Nobuko ; Siegmund, Aaron ; Liu, Longbin...
Journal of Medicinal Chemistry.  54 (2011)  13 - p. 4735-4751 , 2011
Link: https://doi.org/10.1021/..
 
?
13

Structure–Activity Relationships of Phosphoinositide 3-Kina..:

Stec, Markian M. ; Andrews, Kristin L. ; Booker, Shon K....
Journal of Medicinal Chemistry.  54 (2011)  14 - p. 5174-5184 , 2011
Link: https://doi.org/10.1021/..
 
?
14

Discovery and Optimization of a Series of Benzothiazole Pho..:

D'Angelo, Noel D. ; Kim, Tae-Seong ; Andrews, Kristin...
Journal of Medicinal Chemistry.  54 (2011)  6 - p. 1789-1811 , 2011
Link: https://doi.org/10.1021/..
 
?
15

Motesanib inhibits Kit mutations associated with gastrointe..:

Caenepeel, Sean ; Renshaw-Gegg, Lisa ; Baher, Angelo...
Journal of Experimental & Clinical Cancer Research.  29 (2010)  1 - p. , 2010
Link: https://doi.org/10.1186/..
 
1-15